CytomX Therapeutics, Inc. (CTMX)
USD 0.8
(5.9%)
USD 0.8
(5.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 101.21 Million | 53.16 Million | 69.57 Million | 100.36 Million | 57.48 Million | 59.5 Million |
| Cost of Revenue | 2.17 Million | 5.85 Million | 5.83 Million | - | - | - |
| Gross Profit | 99.03 Million | 47.3 Million | 63.73 Million | 100.36 Million | 57.48 Million | 59.5 Million |
| Operating Expenses | 107.69 Million | 154.49 Million | 153.35 Million | 148.96 Million | 168.38 Million | 137.37 Million |
| Selling, General and Administrative Expenses | 30.01 Million | 42.84 Million | 39.16 Million | 36.03 Million | 36.76 Million | 33.51 Million |
| Research and Development Expenses | 77.68 Million | 111.64 Million | 114.19 Million | 112.93 Million | 131.61 Million | 103.86 Million |
| Other Expenses | - | 340 Thousand | -83 Thousand | -27 Thousand | -135 Thousand | -68 Thousand |
| Cost and Expenses | 107.69 Million | 154.49 Million | 153.35 Million | 148.96 Million | 168.38 Million | 137.37 Million |
| Operating Income | -6.48 Million | -101.33 Million | -83.78 Million | -48.6 Million | -110.89 Million | -77.87 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 3.89 Million | -2.01 Million | -2.96 Million | -13.91 Million | -427 Thousand | 14.3 Million |
| Earnings before Tax | 3.32 Million | -99.31 Million | -83.6 Million | -46.79 Million | -102.66 Million | -70.3 Million |
| Net Income | -569 Thousand | -97.29 Million | -80.64 Million | -32.88 Million | -102.23 Million | -84.6 Million |
| Earnings Per Share Basic | -0.01 | -1.48 | -1.26 | -0.71 | -2.26 | -2.03 |
| Earnings Per Share Diluted | -0.01 | -1.48 | -1.26 | -0.71 | -2.26 | -2.03 |
| Weighted Average Shares Outstanding | 73.8 Million | 65.73 Million | 64.14 Million | 46.14 Million | 45.33 Million | 41.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 73.8 Million | 65.73 Million | 64.14 Million | 46.14 Million | 45.33 Million | 41.66 Million |
| Gross Margin | 0.98 | 0.89 | 0.92 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -0.04 | -1.91 | -1.20 | -0.46 | -1.93 | -1.28 |
| Profit Margin | -0.01 | -1.83 | -1.16 | -0.33 | -1.78 | -1.42 |
| EBITDA | -4.3 Million | -98.89 Million | -113.33 Million | -77.96 Million | -138.87 Million | -75.99 Million |
| Earnings Before Tax Margin | -0.06 | -1.91 | -1.20 | -0.48 | -1.93 | -1.31 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 25.11 Million | 41.46 Million | 101.21 Million | 26.6 Million | 26.38 Million | 24.72 Million |
| Cost of Revenue | 459 Thousand | 467 Thousand | 2.17 Million | 486 Thousand | 1.42 Million | 1.53 Million |
| Gross Profit | 24.65 Million | 40.99 Million | 99.03 Million | 26.12 Million | 24.95 Million | 23.19 Million |
| Operating Expenses | 33.1 Million | 29.33 Million | 105.52 Million | 26.72 Million | 23.26 Million | 28.07 Million |
| Selling, General and Administrative Expenses | 8.35 Million | 7.71 Million | - | 7.79 Million | 6.81 Million | 7.4 Million |
| Research and Development Expenses | 24.75 Million | 21.62 Million | - | 18.93 Million | 16.44 Million | 20.67 Million |
| Other Expenses | -2000.00 | -11 Thousand | -30 Thousand | 9000.00 | -7000.00 | -47 Thousand |
| Cost and Expenses | 33.56 Million | 29.8 Million | 107.69 Million | 27.21 Million | 23.26 Million | 28.07 Million |
| Operating Income | -8.45 Million | 11.65 Million | -6.48 Million | -606 Thousand | 3.12 Million | -3.34 Million |
| Interest Expense | - | - | - | 2.34 Million | - | - |
| Income Tax Expense | 51 Thousand | 49 Thousand | 3.89 Million | 1.06 Million | 2.82 Million | -2.3 Million |
| Earnings before Tax | -6.48 Million | 13.84 Million | 3.32 Million | 1.9 Million | 5.81 Million | -1.08 Million |
| Net Income | -6.53 Million | 13.79 Million | -569 Thousand | 837 Thousand | 2.99 Million | -1.08 Million |
| Earnings Per Share Basic | -0.08 | 0.17 | - | 0.01 | 0.04 | -0.02 |
| Earnings Per Share Diluted | -0.08 | 0.17 | - | 0.01 | 0.04 | -0.02 |
| Weighted Average Shares Outstanding | 84.88 Million | 82.02 Million | 73.8 Million | 67.31 Million | 80.73 Million | 66.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 84.88 Million | 82.63 Million | 73.8 Million | 67.31 Million | 80.99 Million | 66.53 Million |
| Gross Margin | 0.98 | 0.99 | 0.98 | 0.98 | 0.95 | 0.94 |
| EBIT Margin | -0.32 | 0.29 | - | -0.00 | 0.12 | -0.11 |
| Profit Margin | -0.26 | 0.33 | -0.01 | 0.03 | 0.11 | -0.04 |
| EBITDA | -7.99 Million | 12.12 Million | - | -120 Thousand | 3.12 Million | -2.73 Million |
| Earnings Before Tax Margin | -0.34 | 0.28 | -0.06 | -0.02 | 0.12 | -0.14 |
OMV
GRPOF
TORO
KALYANIFRG
5657
IDYA